ESMO Virtual Advanced Course on Cancer Vaccines and Cellular Immunotherapy 2022
- Start date
- 29 Apr 2022
- End date
- 30 Apr 2022
- Location
- Virtual, CEST Time
Learning objectives
- To acquire insights in the preclinical and clinical development of vaccines and cellular immunotherapeutic approaches against cancer
- To learn about advances and ongoing research in optimal combinations of immunotherapeutic approaches involving vaccines and cell effectors, along with prognostic and predictive biomarkers
- To obtain in-depth understanding of perspectives, bottlenecks and unmet needs in the evolving field of cancer vaccines and cellular immunotherapies
Accreditation
The programme of this virtual event has been accredited with 7 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-chairs:
- Andrew Furness, United Kingdom
- Pedro Romero, Switzerland